← Back to screener

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB

Rank #2152 · Nasdaq · $0.8B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
31.8
P/E
-2.6
P/B
1.44
ROE
-54.5%
Op. Margin
-166.8%
Debt Ratio
134%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -2.6x, P/B 1.44x. Ranks in the top 58% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -54.5%. Ranks in the top 90% of the universe.

Safety ★★★☆☆
Average

Debt ratio 134%. Ranks in the top 49% of the universe.

Growth ★★★★★
Excellent

Revenue growth of 56.3% year over year. Ranks in the top 7% of the universe.

Growth is the relative strength · Profitability is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B–$-0.1B$-0.1B–-28
2012$0.0B–$-0.1B$-0.2B–-15
2013$0.0B$-0.1B$-0.1B$0.3B-324.17
2014$0.0B$-0.1B$-0.1B$0.2B-363.135
2015$0.0B$-0.1B$-0.1B$0.1B-275.263
2016$0.1B$-0.1B$-0.1B$0.1B-103.783
2017$0.1B$-0.0B$-0.0B$0.1B-31.497
2018$0.1B$-0.1B$-0.1B$0.1B-78.579
2019$0.1B$-0.1B$-0.1B$0.1B-96.166
2020$0.1B$-0.1B$-0.1B$0.1B-128.4108
2021$0.1B$-0.1B$-0.1B$0.1B-110.669
2022$0.1B$-0.1B$0.0B$0.1B-132.32214
2023$0.1B$-0.2B$-0.2B$0.3B-161.2359
2024$0.1B$-0.3B$-0.3B$0.8B-239.4132
2025$0.2B$-0.3B$-0.3B$0.6B-166.8134

← See the full screener